Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis

Annals of Hematology

Volumn 82, Issue 1, 2003, Pages 24-29

  Yeh, Su Peng ^a   Chiu, C F ^a   Lo, W J ^a   Lin, C L ^a   Hsueh, C T ^a   Liao, Y M ^a   Shen, Y C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antimicrobial; Autologous blood stem cell transplantation; Infection

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BUSULFAN; CARMUSTINE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GENTAMICIN; IFOSFAMIDE; IMIPENEM; ITRACONAZOLE; MELPHALAN; MITOXANTRONE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOTRANSPLANTATION; BACTEREMIA; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; MEDICAL DOCUMENTATION; MICROBIOLOGY; MORBIDITY; MORTALITY; MYCOSIS; PERIANAL ABSCESS; PERIPHERAL BLOOD STEM CELL; PHLEBITIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; SIDE EFFECT; BLOOD DISEASE; CLINICAL TRIAL; FEVER; INFECTION; LENGTH OF STAY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

ADULT; ANTIBIOTIC PROPHYLAXIS; COMBINED MODALITY THERAPY; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; INFECTION; LENGTH OF STAY; MIDDLE AGED; MORBIDITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0038351108     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0567-z     Document Type: Article

References (31)

1. Juttner CA, To LB, Roberts MM, et al. (1992) Comparison of haematological recovery, toxicity and supportive care of autologous PBSC, autologous BM and allogeneic BM transplants. Proceedings of the Second International Symposium on Peripheral Blood Stem Cell Autografts, Mulhouse, France, 29 September-2 October 1991. Int J Cell Cloning 10:1-206
2. Schmitz N, Linch DC, Dreger P, et al. (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353-357
3. Hartmann O, Le Corroller AG, Blaise D, et al. (1997) Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. Ann Intern Med 126:600-607
4. Maschmeyer G, Link H, Hiddemann W, et al. (1994) Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 73:2296-2304
5. DePauw BE, Donnelly JP, Dewitte T, et al. (1990) Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant patients. Bone Marrow Transplant 5:179-182
6. Lew MA, Kehoe K, Ritz J, et al. (1991) Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 51:630-636
7. Wimperis JZ, Baglin TP, Marcus RE, Warren RE (1991) An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Bone Marrow Transplant 8:363-367
8. Cruciani M, Rampazzo R, Malena M, et al. (1996) Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 23:795-805
9. Murphy M, Brown AE, Sepkowitz KA, et al. (1997) Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer - is it justified (letter)? Clin Infect Dis 25:346-348
10. Yeh SP, Hsueh EJ, Yu MS, Wu H, Wang YC (1999) Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal. Bone Marrow Transplant 24:1207-1211
11. Beyer J, Schwella N, Zingsem J, et al. (1995) Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 13:1328-1335
12. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE (1997) Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 19:143-147
13. Salazar R, Solá C, Maroto P, et al. (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21:27-33
14. Offidani M, Corvatta L, Olivieri A, et al. (1999) Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 24:1079-1087
15. Seropian S, Nadkarni R, Jillella AP, et al. (1999) Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplant 23:599-605
16. Çelebi H, Akan H, Akçaolayan, E, Üstün C, Arat M (2000) Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 26:211-214
17. Aksu G, Ruhi MZ, Akan H, et al. (2001) Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 27:201-205
18. Herrmann RP, Trent M, Cooney J, Cannell PK (1999) Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 24:1213-1217
19. Wolff SN, Fay J, Stevens D, et al. (2000) Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant 25:853-859
20. Reich G, Mapara MY, Reichardt P, Dörken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525-529
21. Sezer O, Eucker J, Bauhuis C, et al. (2000) Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation. Ann Hematol 79:627-630
22. Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 6:663
23. Shea TC, Mason JR, Storniolo AM, et al. (1992) Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 10:464-473
24. Nosanchuk JD, Sepkowitz KA, Pearse RN, et al. (1996) Infectious complications of bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18:355-359
25. Hughes WT, Armstrong D, Bodey GP, et al. (1997) 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25:551-573
26. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriazone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 119:584-593
27. Kern W, Kurrle E, Schmeiser T (1990) Steptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 18:138-143
28. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (1994) Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer: a trial of oral penicillin V or placebo combined with pefloxacin. JAMA 272:1183-1189
29. Winston DJ, Ho WG, Bruckner DA, et al. (1990) Ofloxacin versus vancomycin/polymyxin for prevention of infection in granulocytopenic patients. Am J Med 99:36-42
30. Uderzo C, D'Angelo P, Rizzari C, et al. (1992) Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 9:113-117
31. Wing EJ, Hart II RB (2000) Infection prophylaxis - bacteria. In: Ball ED, Lister J, Law P (eds) Hematopoietic stem cell therapy, 1st edn. Churchill Livingstone, Philadelphia, pp 427-428